These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11571359)

  • 1. Intoxication with riluzole in Huntington's disease.
    Bodner T; Jenner C; Benke T; Ober A; Seppi K; Fleischhacker WW
    Neurology; 2001 Sep; 57(6):1141-3. PubMed ID: 11571359
    [No Abstract]   [Full Text] [Related]  

  • 2. Riluzole in Huntington's disease: a 3-year, randomized controlled study.
    Landwehrmeyer GB; Dubois B; de Yébenes JG; Kremer B; Gaus W; Kraus PH; Przuntek H; Dib M; Doble A; Fischer W; Ludolph AC;
    Ann Neurol; 2007 Sep; 62(3):262-72. PubMed ID: 17702031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riluzole in Huntington's disease (HD): an open label study with one year follow up.
    Seppi K; Mueller J; Bodner T; Brandauer E; Benke T; Weirich-Schwaiger H; Poewe W; Wenning GK
    J Neurol; 2001 Oct; 248(10):866-9. PubMed ID: 11697523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed amnesic syndrome after riluzole autointoxication in Huntington disease.
    Haaxma CA; Kremer HP; van de Warrenburg BP
    Neurology; 2006 Apr; 66(7):1123-4. PubMed ID: 16606937
    [No Abstract]   [Full Text] [Related]  

  • 5. Dosage effects of riluzole in Huntington's disease: a multicenter placebo-controlled study.
    Huntington Study Group
    Neurology; 2003 Dec; 61(11):1551-6. PubMed ID: 14663041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riluzole therapy in Huntington's disease (HD).
    Rosas HD; Koroshetz WJ; Jenkins BG; Chen YI; Hayden DL; Beal MF; Cudkowicz ME
    Mov Disord; 1999 Mar; 14(2):326-30. PubMed ID: 10091628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of riluzole in Huntington's disease.
    Squitieri F; Ciammola A; Colonnese C; Ciarmiello A
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):221-2. PubMed ID: 17987289
    [No Abstract]   [Full Text] [Related]  

  • 8. Perseveration and Suicide in Huntington's Disease.
    Roman OC; Stovall J; Claassen DO
    J Huntingtons Dis; 2018; 7(2):185-187. PubMed ID: 29614688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral megadose methylphenidate ingestion for suicide attempt.
    Fettahoglu EC; Satilmis A; Gokcen C; Ozatalay E
    Pediatr Int; 2009 Dec; 51(6):844-5. PubMed ID: 20158630
    [No Abstract]   [Full Text] [Related]  

  • 10. [Frontal dysfunctions in Huntington's disease -- neuropsychology and therapy].
    Weimer E; Ries S; Tost H; Braus DF
    Psychiatr Prax; 2003 Jan; 30(1):33-6. PubMed ID: 12524580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family break-down and stress in Huntington's chorea.
    Tyler A; Harper PS; Davies K; Newcome RG
    J Biosoc Sci; 1983 Apr; 15(2):127-38. PubMed ID: 6221016
    [No Abstract]   [Full Text] [Related]  

  • 12. Sustained bradycardia during fluvoxamine and buspirone intoxication.
    Langlois RP; Paquette D
    Can J Psychiatry; 1994 Mar; 39(2):126-7. PubMed ID: 8149317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Amisulpride in Huntington's disease].
    Saft C; Andrich J; Kraus PH; Przuntek H
    Psychiatr Prax; 2005 Oct; 32(7):363-6. PubMed ID: 16220421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of fluoxetine in overdose.
    Moore JL; Rodriguez R
    Am J Psychiatry; 1990 Aug; 147(8):1089. PubMed ID: 2375446
    [No Abstract]   [Full Text] [Related]  

  • 15. Attempted suicide using insulin by a non diabetic: a case study demonstrating the acute and chronic consequences of profound hypoglycemia.
    Cooper AJ
    Can J Psychiatry; 1994 Mar; 39(2):103-7. PubMed ID: 8149313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-fatal effect of highly toxic amitriptyline level after suicide attempt. A case report].
    Amann B; Grunze H; Hoffmann J; Schäfer M; Kuss HJ
    Nervenarzt; 2001 Jan; 72(1):52-5. PubMed ID: 11221556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel therapies for Huntington's disease: hope and challenge.
    Qin ZH; Wang J; Gu ZL
    Acta Pharmacol Sin; 2005 Feb; 26(2):129-42. PubMed ID: 15663888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric implications of presymptomatic testing for Huntington's disease.
    Kessler S
    Am J Orthopsychiatry; 1987 Apr; 57(2):212-219. PubMed ID: 2954468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monozygotic twins suffering from Huntington's disease show different cognitive and behavioural symptoms.
    Gómez-Esteban JC; Lezcano E; Zarranz JJ; Velasco F; Garamendi I; Pérez T; Tijero B
    Eur Neurol; 2007; 57(1):26-30. PubMed ID: 17108691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical periods of suicide risk in Huntington's disease.
    Paulsen JS; Hoth KF; Nehl C; Stierman L
    Am J Psychiatry; 2005 Apr; 162(4):725-31. PubMed ID: 15800145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.